Literature DB >> 6602847

A rapid, large scale purification procedure for gibbon interleukin 2.

L E Henderson, J F Hewetson, R F Hopkins, R C Sowder, R H Neubauer, H Rabin.   

Abstract

Interleukin 2 (IL 2) was purified from the conditioned medium of a gibbon T cell line, MLA144, which releases IL 2 constitutively. The IL 2 was obtained free of contaminating proteins by a simple process consisting of an initial batch purification on trimethylsilyl-controlled pore glass followed by reversed phase high pressure liquid chromatography. Overall recovery of IL 2 activity ranged from 70 to 100% of initial activity and yielded 2 X 10(6) or greater units of IL 2 per 15 liters of serum-free MLA144 conditioned medium. The specific activity of purified IL 2 ranged from 0.5 to 1 X 10(8) IL 2 U/mg protein. The purified IL 2 showed four molecular species when analyzed by two-dimensional isoelectric focusing-SDS-polyacrylamide gel electrophoresis. Each of the four molecular forms was active in the bioassay for IL 2 activity. Three molecular forms had apparent m.w. of 16,000 but different isoelectric points of 5.9, 6.3, and 6.7. One molecular form had an apparent m.w. of 15,000 and an isoelectric point of 7.2. The most abundant form of IL 2 had an apparent m.w. of 16,000 and an isoelectric point of 6.3. The purified IL 2 supported the growth of IL 2-dependent lymphocytes to a greater extent than did the same level of crude IL 2-containing MLA144 conditioned medium. The ability to purify large amounts of IL 2 by a rapid and efficient procedure will be of great help in both biochemical and immunologic studies of this lymphokine.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6602847

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Immunoregulation in the common marmoset, Calithrix jaccus: functional properties of T and B lymphocytes and their response to human interleukins 2 and 4.

Authors:  D J Quint; S P Buckham; E J Bolton; R Solari; B R Champion; E D Zanders
Journal:  Immunology       Date:  1990-04       Impact factor: 7.397

2.  The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor.

Authors:  D S Milstone; C W Parker
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

3.  Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation.

Authors:  Y Reisner; I Ben-Bassat; D Douer; A Kaploon; E Schwartz; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Biology of interleukin-2.

Authors:  F W Ruscetti
Journal:  Surv Immunol Res       Date:  1984

5.  Corticosteroid-interleukin 2 interactions: inhibition of binding of interleukin 2 to interleukin 2 receptors.

Authors:  H J Horst; H D Flad
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  Chemical reduction of oxidized human lymphocytes inhibits interleukin 2 production but not induction of interleukin 2 responsiveness.

Authors:  E Roffman; B Sredni; A Smolinsky; M Wilchek
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

7.  Transformation of owl monkey T cells in vitro with Herpesvirus saimiri.

Authors:  H Rabin; R F Hopkins; R C Desrosiers; J R Ortaldo; J Y Djeu; R H Neubauer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

8.  Lymphocyte function in human bone marrow. II. Characterization of an interleukin 2-sensitive T precursor-cell population.

Authors:  H M Dosch; C J Ledgley; D White; P Lam; G B Mills
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

9.  Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution-partition analysis.

Authors:  M C Cerrone; D M Ritter; R E Kuhn
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 10.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.